-
Final result squeeze-out [FR] [NL]
-
-
-
Latest Innogenetics Press Releases
November 13, 2008 Solvay Group holds 95.33% of Innogenetics shares
Solvay will proceed with squeeze-out of remaining Innogenetics shares and request delisting.
[EN]-[FR]-[NL]
October 15, 2008 Solvay Group holds 93.1% of Innogenetics
Offer on Innogenetics shares is extended from 22 October to 12 November
[EN]-[FR]-[NL]
September 09, 2008 Solvay Pharmaceuticals acquires Innogenetics
Solvay Group holds 84.3% of Innogenetics shares
[EN]-[FR]-[NL]
July 24, 2008 Solvay Pharmaceuticals S.A. plans the offer period for Innogenetics from August 12 to September 5, 2008
Solvay Pharmaceuticals S.A., a subsidiary of Solvay, the chemical and pharmaceutical group, today announced that it plans the offer period to acquire Innogenetics N.V., a Belgian-based biotechnological company, from August 12 to September 5, pending approval of the takeover prospectus by Belgium’s Banking, Finance and Insurance Commission (CBFA).
[EN]-[FR]-[NL]
July 09, 2008 Solvay Pharmaceuticals S.A. increases to eur 6.50 per share its initial tender offer to acquire Innogenetics
Solvay Pharmaceuticals S.A., a subsidiary of Solvay, the chemical and pharmaceutical group, today announced that it will increase its initial conditional tender offer to acquire Innogenetics N.V., a Belgian-based biotechnological company, in a cash transaction valued at EUR 6.50 per share.
[EN]-[FR]-[NL]
April 25, 2008 SOLVAY PHARMACEUTICALS S.A. LAUNCHES FRIENDLY BID TO ACQUIRE INNOGENETICS
Building on a successful R&D co-operation
[EN]-[FR]-[NL]
